Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Performance Study of the Use of EmboBio for the Intra-arterial Treatment of Abdominopelvic Bleeding: EMBOBIO-1

NCT07199348 is registered in ClinicalTrials.gov with Embobio Medical as lead sponsor.

NCT NCT07199348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07199348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Performance Study of the Use of EmboBio for the Intra-arterial Treatment of Abdominopelvic Bleeding: EMBOBIO-1
Lead sponsor
Embobio Medical
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 8, 2025
Completion date
April 30, 2027
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdomino-pelvic surgery, bleeding, embolization